These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31364081)

  • 41. Clinical Use of Polymyxin B.
    Rigatto MH; Falci DR; Zavascki AP
    Adv Exp Med Biol; 2019; 1145():197-218. PubMed ID: 31364080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells.
    Mingeot-Leclercq MP; Tulkens PM; Denamur S; Vaara T; Vaara M
    Peptides; 2012 Jun; 35(2):248-52. PubMed ID: 22504013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves.
    Ziv G; Nouws JF; van Ginneken CA
    J Vet Pharmacol Ther; 1982 Mar; 5(1):45-58. PubMed ID: 6284955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility testing of the polymyxins: where are we now?
    Humphries RM
    Pharmacotherapy; 2015 Jan; 35(1):22-7. PubMed ID: 25329490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS.
    BARNETT M; BUSHBY SR; WILKINSON S
    Br J Pharmacol Chemother; 1964 Dec; 23(3):552-74. PubMed ID: 14256814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging the distribution of polymyxins in the kidney.
    Yun B; Azad MA; Wang J; Nation RL; Thompson PE; Roberts KD; Velkov T; Li J
    J Antimicrob Chemother; 2015 Mar; 70(3):827-9. PubMed ID: 25377569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin.
    Vaara M
    Med Res Rev; 2018 Sep; 38(5):1661-1673. PubMed ID: 29485690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colistin in critically ill patients.
    Boisson M; Gregoire N; Couet W; Mimoz O
    Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymyxin-Induced Metabolic Perturbations in Human Lung Epithelial Cells.
    Ahmed MU; Azad MAK; Li M; Creek DJ; Han M; Zhou F; Chan K; Zhou QT; Velkov T; Li J
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0083521. PubMed ID: 34228550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Labelling Conventions and Product Package Insert of Parenteral Polymyxins: Factors Causing Potential Medication Errors and Impeding Optimal Clinical Use.
    Li J; Coulthard K; Nation RL
    Adv Exp Med Biol; 2019; 1145():133-141. PubMed ID: 31364076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 55. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies.
    Oliota AF; Penteado ST; Tonin FS; Fernandez-Llimos F; Sanches AC
    Diagn Microbiol Infect Dis; 2019 May; 94(1):41-49. PubMed ID: 30635223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methionine Ameliorates Polymyxin-Induced Nephrotoxicity by Attenuating Cellular Oxidative Stress.
    Azad MAK; Sivanesan S; Wang J; Chen K; Nation RL; Thompson PE; Roberts KD; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of Novel Polymyxin-Like Antibiotics.
    Velkov T; Roberts KD
    Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
    Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of Polymyxin Resistance.
    Moffatt JH; Harper M; Boyce JD
    Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.